ENTITY

Scribe Therapeutics (SCTX US)

10
Analysis
Health Care • United States
Scribe Therapeutics Inc. is a clinical-stage biotechnology company. The Company develops CRISPR-based genetic medicines for the treatment of cardiovascular and metabolic diseases. Scribe Therapeutics operates in the United States.
more
Exchange Announcement • 03 Sep 2026 04:08

Current Report (Form 8-K | Period ending 2026-09-02)

Exchange Announcement • 02 Sep 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 28 Jul 2026 05:08

Current Report (Form 8-K | Period ending 2026-07-27)

Exchange Announcement • 24 Jul 2026 07:35

S-1MEF | A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1

No more filings
x